谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Long-term Follow-up of Zimberelimab in Relapsed or Refractory Classic Hodgkin Lymphoma: Insights from the Phase Ⅱ YH-S001-04 Clinical Trial

Suisui Kan,Hai Bai,Hui Liu, Jie Cui,Xiaoyan Ke,Huilai Zhang,Lihong Liu,Dongmei Yan,Yongsheng Jiang,Aimin Zang,Junyuan Qi,Li Wang,Zhuogang Liu,Bing Xu,Ying Zhang,Zhihui Zhang,Xielan Zhao,Chunhong Hu,Shenmiao Yang,Hui Zhou, Jinsheng Shi, Zonghong Shao, Ying Xiang, Ningjing Lin, Mingzhi Zhang

LEUKEMIA RESEARCH（2025）

引用 0|浏览2
关键词
Hodgkin Lymphoma,Relapsed/Refractory,PD-1 inhibitors,Zimberelimab,Efficacy,Safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要